Week in Review: March 21–25

Smallest genome yet; MERS-CoV in Kenya; FDA approves new Zika diagnostic; matching private funders with unfunded NIH grant applications; monitoring mRNA with CRISPR

Mar 25, 2016
Tracy Vence
  • Scientists build a living cellular organism with a genome smaller than any known in nature.

  • Researchers report evidence of past Middle East respiratory syndrome coronavirus infection in two people in Kenya.

  • Bioethicist Arthur Caplan of New York University Langone Medicine Center reviews The Scientist Senior Editor Jef Akst’s debut book, Personal Trials.
     

Other news in life science:

New Test for Zika OKed
The US Food and Drug Administration gave emergency approval for a combination diagnostic that can distinguish between Zika, dengue, and chikungunya infections.

Finding Funding for Rejected NIH Proposals
The National Institutes of Health joins forces with a tech company to launch a matchmaking program that aims to help investigators find secondary funding sources.

Karolinska Lets Macchiarini Go
The embattled artificial organ researcher has been dismissed over the fallout from several misconduct allegations leveled against him.

Neural Basis of Risk Aversion
Researchers identify and manipulate a signal in the brains of rats that controls risky behavior.

CRISPR Can Tag RNA
Modifications to the DNA-slicing program allow for monitoring the movement of messenger RNA.